Cantor Fitzgerald Maintains Fennec Pharmaceuticals (FENC) Overweight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on April 6, 2023,
Cantor Fitzgerald
maintained
coverage of Fennec Pharmaceuticals (NASDAQ:FENC) with
a Overweight recommendation.
Cantor Fitzgerald
maintained
coverage of Fennec Pharmaceuticals (NASDAQ:FENC) with
a Overweight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1917868586-d64880817bca4098bc8be36bbd17a4e9.jpg "Should You Trade Options on Spot Bitcoin ETFs?")